Trade Ideas March 27, 2026

Perma-Fix Looks Poised For A Strong H2 '26 - Tactical Long Setup

PFAS commercialization and DOE contract work should drive revenue traction while the stock clears a technical base below $11.

By Derek Hwang PESI
Perma-Fix Looks Poised For A Strong H2 '26 - Tactical Long Setup
PESI

Perma-Fix (PESI) has a credible path to outsized H2 2026 revenue and margin improvement driven by nuclear waste volumes, recent pilot success on PFAS destruction, and new government contract access. The balance sheet is manageable, and the stock sits near an oversold technical footprint with short interest elevated - set up a disciplined long with defined stop and a realistic target at the 52-week high.

Key Points

  • Perma-Fix combines federal DD&R contract access with a patent-pending PFAS destruction process moving toward commercialization.
  • Market cap ~ $203.8M and EV ~ $192.6M; current multiples reflect growth/turnaround status (price-to-sales ~3.27, negative EPS).
  • Recent operational momentum: Q3 2025 revenue grew ~45% YoY driven by higher waste volumes and international shipments.
  • Technical setup is favorable: RSI ~32 (near oversold) with elevated short interest that can amplify upside on positive catalysts.

Hook & thesis

Perma-Fix Environmental Services (PESI) has been quietly checking boxes that support a durable revenue step-up into H2 2026: expanding DOE and federal program access, pilot-to-commercial steps on a patent-pending PFAS destruction process, and visibly higher waste volumes in recent quarters. At $10.99 the shares already price in a lot of uncertainty, but the risk/reward looks attractive for a tactical long because the company pairs contract-backed service revenues with a proprietary technology that could re-rate multiples if commercial adoption accelerates.

My trade thesis: buy PESI for a long-term trade (180 trading days) targeting the recent 52-week peak around $16.50. Entry at $11.00 keeps execution simple, stop at $9.00 limits downside to a controlled level, and the path to target is supported by both fundamental catalysts and a technical base that currently shows oversold indicators.

What Perma-Fix does and why the market should care

Perma-Fix is a niche industrial services company focused on nuclear waste management and on-site waste services, operating through Treatment and Services segments. Its capabilities include processing and disposal of low-level radioactive, mixed hazardous, and non-hazardous wastes, plus on-site technical nuclear services. Two items make this more than a boring environmental contractor:

  • Contract access to large federal programs: the company was selected to participate in a 10-year DOE DD&R small business IDIQ (05/03/2024), which opens a predictable avenue to federally funded deactivation, decommissioning and removal work across DOE, NNSA and naval sites.
  • New PFAS destruction tech moving toward commercialization: Perma-Fix completed pilot plant testing for a patent-pending PFAS destruction process (04/03/2024) and has selected a fabricator for the first commercial unit (06/12/2024). PFAS remediation is a large and growing remediation market where permanent destruction - not just containment - commands premium pricing.

Those two levers - recurring federal DD&R work and a commercialization pathway for PFAS destruction - give Perma-Fix a credible route to higher, less lumpy revenues and improving margins in H2 2026 if execution stays on plan.

Data-driven support

Here are the hard numbers to anchor the thesis:

  • Market capitalization: roughly $203.8 million, which keeps Perma-Fix in micro/small-cap territory but large enough to fund near-term commercialization and contracts.
  • Recent operational performance: management reported a 45% year-over-year revenue increase in Q3 2025 driven by higher waste volumes and international shipments (11/10/2025). That shows the business can scale volumes when opportunities materialize.
  • Profitability and cash flow: trailing EPS remains negative at about -$0.74 and free cash flow is negative (-$15.46M), so the story still requires operational improvement to deliver durable profits.
  • Balance sheet and leverage: debt-to-equity is low (~0.06), which limits financial stress and leaves room for capital spending into the PFAS unit or contract mobilization. Current and quick ratios (1.40 and 1.34) indicate reasonable short-term liquidity.
  • Valuation context: price-to-sales sits near 3.27 and EV/sales around 3.12, with price-to-book roughly 4.0. Those multiples are not cheap, but they reflect a small-cap growth/turnaround profile where revenue growth and a move toward positive free cash flow would justify a re-rating.
  • Technicals and market structure: RSI is ~32, signaling oversold conditions. The 50-day SMA ($13.86) remains above price, but the stock is constructing a base just below $11. Short interest is elevated (~1.2M shares with days-to-cover around 11 as of 03/13/2026), which both increases downside volatility and creates the potential for squeeze dynamics on positive news.

Valuation framing

At a market value of about $204M and an enterprise value near $193M, investors are effectively valuing Perma-Fix as a growth-or-turnaround services company that must prove scaling and margin improvement. Earnings are negative today, so traditional P/E valuation is irrelevant; instead the focus should be on EV/sales and on the potential for a revenue lift from DOE contract work and PFAS commercial units.

If Perma-Fix can convert pilot PFAS work into a commercial unit and add recurring DOE DD&R revenues, even modest margin expansion could move the company from a negative free cash flow profile to breakeven or better. In that scenario the market would likely accept a higher revenue multiple; hitting $16.50 would imply a re-rating toward the upper end of the small-cap industrial services peer group — reasonable if execution validates the technology and contract book.

Catalysts to watch (near- to mid-term)

  • Commercialization milestones for PFAS destruction - fabrication progress, first commercial unit startup, and early revenue recognition from that unit.
  • New awards or task orders under the DOE DD&R IDIQ that materially increase backlog and visibility into H2 2026 revenue.
  • Quarterly results that show continued volume growth (repeat of the +45% YoY quarter) and narrowing losses or improved cash flow trends.
  • Positive operational updates or pilot results from large commercial customers which could accelerate adoption and pricing power.

Trade plan (actionable)

Direction: Long (buy)

Entry Price: $11.00

Stop Loss: $9.00

Target Price: $16.50

Horizon: long term (180 trading days) - Here’s why: commercialization, contract awards, and quarterly visibility around PFAS and DOE revenues take time to materialize. Expect the trade to play out over multiple quarters as revenue recognition and margin expansion are gradual.

Execution notes: enter on light-to-moderate size to limit exposure to headline-driven moves. If you prefer a scaled entry, consider half at $11.00 and add on confirmation of commercialization progress or a larger-than-expected DOE task order. Tight stop placement at $9.00 protects capital if the macro environment or contract pipeline disappoints.

Risks and counterarguments

Perma-Fix is not a low-risk holding. I outline the main risks below and include at least one counterargument to the bullish case.

  • Execution risk on PFAS commercialization: pilot success does not guarantee commercial success. Engineering scale-up surprises, regulatory hurdles, or slower-than-expected customer uptake could delay revenue and keep cash burn elevated.
  • Revenue concentration and lumpiness: a meaningful part of revenue comes from large project work that can be timing-driven. A pause in project awards or slow mobilization would hit quarterly results hard.
  • Negative cash flow and financing risk: free cash flow is negative (-$15.46M). If operational improvement is slower than expected, Perma-Fix could need additional funding that dilutes shareholders or raises the cost of capital.
  • High short interest and volatility: elevated short interest (~1.2M shares) can amplify downside on disappointing news. Days-to-cover near double digits means squeeze potential but also increased risk of sharp selloffs.
  • Regulatory and environmental liability risk: working in nuclear and hazardous waste inherently includes regulatory scrutiny and potential remediation liabilities that can be expensive and slow to resolve.

Counterargument

An equally valid contrarian view is that the market is correctly skeptical and the company will struggle to move from pilot to repeatable, margin-accretive commercial PFAS installations. If PFAS units underperform economically or DOE work proves more competitive and lower-margin than expected, the valuation could compress further and the stock might revisit lower support levels. That’s why the trade has a defined stop and a moderate risk profile.

What would change my mind

I would reduce conviction if any of the following occur over the next two quarters: (a) PFAS commercialization milestones are missed or delayed without credible remediation plans; (b) the company prints another quarter of sharply widening losses and shows negative visibility to H2 2026 revenue; or (c) cash runway concerns force dilutive financing without clear allocation to revenue-generating assets. Conversely, my bullish view would strengthen if Perma-Fix announces early commercial PFAS revenue, multiple DOE task orders, or a quarter with clear margin improvement and narrowing free cash flow loss.

Conclusion

Perma-Fix is a classic small-cap turnaround-with-optionalities story: it combines recurring, contract-backed services with a technology optionality that addresses a large remediation market. At $11.00 entry targeting $16.50 over 180 trading days, the trade balances upside potential tied to commercialization and contract wins with downside control through a $9.00 stop.

This is a pragmatic, event-driven trade for investors willing to tolerate higher volatility in exchange for asymmetric upside if Perma-Fix executes on PFAS commercialization and wins meaningful DOE work in H2 2026.

Risks

  • PFAS commercialization may face scale-up, regulatory, or customer-adoption hurdles delaying revenue recognition.
  • Business is project-driven and lumpy; a slowdown in task orders or mobilization timing could pressure results.
  • Negative free cash flow (~-$15.46M) raises the risk of future financing and shareholder dilution if operational improvement lags.
  • High short interest (~1.2M shares) increases downside volatility and the potential for rapid share-price swings.

More from Trade Ideas

Buy the Dip: Nvidia’s Pullback Hands You a Mid-Run Entry Into the AI Cycle Mar 27, 2026 Tactical Long on Meta: Buy the AI Sell-Off While Cash-Multiple Compresses Mar 27, 2026 Lumentum: Photonics Momentum Beyond AI - A Tactical Long Mar 27, 2026 Garrett Motion: Position for 2026 Growth, Buy on Current Levels Mar 27, 2026 Nebius’ Hidden Revenue Stream: Betting on a $45B+ Backlog to Drive a Mid-Term Rally Mar 27, 2026